20 research outputs found

    Mutations in PYCR2, Encoding Pyrroline-5-Carboxylate Reductase 2, Cause Microcephaly and Hypomyelination

    Get PDF
    Despite recent advances in understanding the genetic bases of microcephaly, a large number of cases of microcephaly remain unexplained, suggesting that many microcephaly syndromes and associated genes have yet to be identified. Here, we report mutations in PYCR2, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal microcephaly, hypomyelination, and reduced cerebral white-matter volume. Linkage mapping and whole-exome sequencing identified homozygous mutations (c.355C>T [p.Arg119Cys] and c.751C>T [p.Arg251Cys]) in PYCR2 in the affected individuals of two consanguineous families. A lymphoblastoid cell line from one affected individual showed a strong reduction in the amount of PYCR2. When mutant cDNAs were transfected into HEK293FT cells, both variant proteins retained normal mitochondrial localization but had lower amounts than the wild-type protein, suggesting that the variant proteins were less stable. A PYCR2-deficient HEK293FT cell line generated by genome editing with the clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 system showed that PYCR2 loss of function led to decreased mitochondrial membrane potential and increased susceptibility to apoptosis under oxidative stress. Morpholino-based knockdown of a zebrafish PYCR2 ortholog, pycr1b, recapitulated the human microcephaly phenotype, which was rescued by wild-type human PYCR2 mRNA, but not by mutant mRNAs, further supporting the pathogenicity of the identified variants. Hypomyelination and the absence of lax, wrinkly skin distinguishes this condition from that caused by previously reported mutations in the gene encoding PYCR2’s isozyme, PYCR1, suggesting a unique and indispensable role for PYCR2 in the human CNS during development

    Provoked seizures in 5-second raw data traces of action potentials.

    No full text
    <p><b>a:</b> Baseline activity before PTZ addition. <b>b:</b> A typical seizure starting with a prolonged action potential burst 1–2 minutes after PTZ application. <b>c:</b> Seizures continue as short paroxysmal action potential bursts. PTZ addition leads to a seizure firing pattern. Markings denote sustained (> 2 sec; b) versus short (< 500 ms; c) bursting.</p

    Confirmation of cell stability.

    No full text
    <p>Top panels in (<b>a)</b> show representative single cell recordings before and after KCl addition, top panels in (<b>b</b>) before and after PTZ addition. Bottom panels show averages of baseline and KCl recordings (<b>a</b>) and of baseline and PTZ recordings (<b>b</b>). Dashed lines indicate the width of the averaged action potential at half maximum of the amplitude and they approximate 1.3 ms in both recordings. Action potentials are stable over time as indicated by the unchanged shape of the traces.</p

    Addition of TTX to seizing larvae abolishes spiking.

    No full text
    <p>Spike rate plotted as a function of time (one channel shown). Recordings are made before and after PTZ addition. The addition of 0.4 mM TTX at 3900 s abolished firing. These experiments demonstrate a high likelihood that recorded signals arise from neurons firing action potentials (in contrast to myogenic potentials arising from tail-movements).</p

    Increase in active electrode firing fraction and spatial coherence of electrical activity after drug addition.

    No full text
    <p><b>a:</b> Area under the curve (AUC), a numerical integration, of the total firing fraction between baseline and post-drug periods shows significant increase (** p < 0.01, *** p < 0.001) after KCl (p = 0.0009) and PTZ (p = 0.002) addition relative to baseline. Note the similarity in the firing fraction across time when no drug (sham) was added to the bath (p = 0.86). <b>b:</b> Area under the curve of spatial coherence, a measure derived by comparing the correlation of coefficient of a central pixel with respect to its nearest-matching neighbor along time, also did not differ between baseline and follow-up in the sham condition (p = 0.19). Notably, more channels fired simultaneously indicating a significant increase (* p < 0.05, ** p < 0.01) in spatial coherence after KCl (p = 0.002) and PTZ (p = 0.02) administration.</p

    Tools and steps for larva-mounting and timeline of recording.

    No full text
    <p><b>a:</b> Electrode chamber used for recordings (scale: 10 mm). <b>b:</b> Nylon mesh and slice anchor used to hold larva in place (scale: 5 mm). <b>c:</b> Placement of larva onto its dorsal side into the chamber with a drop of water (scale: 300 μm). <b>d:</b> Securing larva with nylon mesh (scale: 300 μm); microelectrode array is highlighted with red dots for enhanced visibility in this photo and the next. <b>e:</b> Larva positioned with head onto the microelectrode array (scale 300 μm). <b>f:</b> Timeline for experiments—each starting with a 15 min acclimation period, a 30 min control recording, and a 30 min recording time after drug application.</p

    Spike rate and burst rate increase after drug-addition.

    No full text
    <p><b>a:</b> Summary statistics of recordings from all active channels show a significant increase (** p < 0.01) in spike rate across all experiments following KCl (p = 0.001) or PTZ addition (p = 0.001) to the bath in contrast to the sham condition (p = 0.87). <b>b:</b> Summary statistics of recordings from all active channels show a significant increase (* p < 0.05, *** p < 0.001) of bursting across all experiments following KCl (p = 0.0006) and PTZ addition (p = 0.02) to the bath in contrast to the sham-condition (p = 0.53). The addition of the chemical convulsants KCl and PTZ leads to an increase in firing and bursting of action potentials.</p
    corecore